References
- Arrigoni-Martelli E., Nielsen C. K., Olsen U. B., Petersen H. J. N-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator. Experientia 1980; 36: 445–447
- Dalgaard L. Preparation and hydrolysis ofN-glucuronides of pyridine and piperidine. Acta Chemica Scandinavica 1983; B37: 923–928
- De Long A. F., Oldham S. W., De Sante K. A., Nell G., Henry D. P. Disposition of [14C]pinacidil in humans. Journal of Pharmaceutical Sciences 1988; 77: 153–156
- Eilertsen E., Magnussen M. P., Petersen H. J., Rastrup-Andersen N., SØRensen H., Arrigoni-Martelli E. Metabolism of the new antihypertensive agent pinacidil in rat, dog and man. Xenobiotica 1982; 12: 187–196
- Kardel T., Hilden T., Carlsen J., Trap-Jensen J. N“-cyano-N-4-pyridyl-N”-1,2,2-trimethylpropylguanidine, a new vasodilating agent: acute effect on blood pressure and pharmacokinetics in hypertensive patients. Journal of Cardiovascular Pharmacology 1981; 3: 1002–1007
- Petersen H. J., Nielsen C. K., Arrigoni-Martelli E. Synthesis and hypotensive activity ofN-alkyl-N-cyano-N'-pyridylguanidines. Journal of Medicinal Chemistry 1978; 21: 773–781
- Rubin A., Dhahir P. H., Crabtree R. E., Henry D. P. The disposition ofl-3-[(dimethylamino)-(m-dioxan-5-yl)methyl]pyridine in man. Drug Metabolism and Disposition 1979; 7: 149–154
- Sakamoto K., Nakamura Y. Urinary metabolites of pinacidil: I. Isolation and identification of the urinary metabolites of pinacidil in rat urine. Xenobiotica 1993, submitted
- Thomas R. C., Harpootlian H. Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeys. Journal of Pharmaceutical Sciences 1975; 64: 1366–1371
- Weston A. H., Bray K. M., Duty S., McHarg A. D., Newgreen D. T., Southerton J. S. In vitro studies on the mode of action of pinacidil. Drugs 1988; 36: 10–28